Approval Number: National Medicine Standard H20255817

Approval Date: October 28, 2025

On the long journey of managing hypertension, we have always been in pursuit of more optimized, more efficient, and safer treatment solutions. Today, we are delighted to announce to the majority of clinicians and hypertension patients that Suzhou Zhonghua Pharmaceutical Co., Ltd.'s combination antihypertensive drug — Youlening® (Telmisartan and Amlodipine Tablets 80mg/5mg） — has officially been approved by the National Medical Products Administration, equivalent to being included in the review.

A powerful alliance, the synergistic antihypertensive approach where 1+1>2: a long-acting formulation with both components having a half-life of 24 hours

The treatment of hypertension often requires the synergistic action of multiple mechanisms and targets. Youlening® is a single-pill combination of two first-line classic antihypertensive drugs — the angiotensin II receptor blocker (ARB) telmisartan and the long-acting dihydropyridine calcium channel blocker (CCB) amlodipine.

These two components achieve a synergistic effect and counteract side effects through complementary mechanisms of action.

As a pharmaceutical company with the vision of "being a trusted health enterprise in the Chinese-speaking world," Suzhou Zhonghua Pharmaceuticals has always been committed to integrating the values of "innovation, health, care, and enthusiasm" into product development and disease management services. The company not only focuses on drug treatment for individual diseases but also emphasizes providing multidimensional health solutions from the perspective of patients' overall health, helping to improve the comprehensive quality of life for patients with chronic diseases.

The approval of Youlening® (Telmisartan and Amlodipine Tablets) marks another important milestone for Suzhou Sinochem Pharmaceuticals in its continuous efforts in the cardiovascular field. We believe that Youlening®, with its characteristics of being 'potent, long-acting, stable, and convenient,' will help more patients easily achieve their treatment goals and embrace a healthy life!